Research / FBRT / Fundamental state Inspectable configuration
State dimensions Filing 0001562528-24-000025 Reit
Operating-cash-flow growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.operating_cash_flow
-95.76% · OPTIONAL · NOT_ENOUGH_HISTORY
Net-income growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.net_income
-105.49% · CORE · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-36.75% · CORE · NOT_ENOUGH_HISTORY
Cash and equivalents 0th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.cash
$94.8M · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 11 states History building
Sep 30, 2023 0/4 normalized Level 3 Dec 31, 2023 0/4 normalized Level 3 Mar 31, 2024 0/4 normalized Level 3 Jun 30, 2024 1/4 normalized Level 3 Sep 30, 2024 1/4 normalized Level 3 Dec 31, 2024 1/4 normalized Level 3 Mar 31, 2025 1/4 normalized Level 3 Sep 30, 2025 3/4 normalized Level 3 Dec 31, 2025 4/4 normalized Level 3 Mar 31, 2026 4/4 normalized Level 3 Jun 30, 2026 4/4 normalized Level 3 Period transition
What moved in the state? Cash Generation Decreased
Previous -61.00%
Current -95.76%
Delta -34.76% Earnings Growth Decreased
Previous -18.05%
Current -105.49%
Delta -87.44% Growth Decreased
Previous 42.27%
Current -36.75%
Delta -79.02% Liquidity Decreased
Previous $240.0M
Current $94.8M
Delta -$145.3M Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.